Streetbeat News

Products Services

MOB

Mobilicom has launched its next-generation 8-inch Controller Pro, which could enhance its product offerings and market position.

Portfolio Pulse from Benzinga Newsdesk

September 04, 2024 | 11:11 am

ELDN

Eledon Pharmaceuticals has completed enrollment for its Phase 2 BESTOW clinical trial, which focuses on preventing organ rejection in kidney transplant patients.

Portfolio Pulse from Benzinga Newsdesk

September 04, 2024 | 11:10 am

ARBE

Arbe Robotics' Tier-1 partner, Sensrad, has signed a framework agreement to supply 4D imaging radars, powered by Arbe's chipset, to Tianyi Transportation Technology in China. This partnership could enhance Arbe's market presence in China.

Portfolio Pulse from Benzinga Newsdesk

September 04, 2024 | 11:09 am

NTRB

Nutriband reported cash reserves of $6.75 million as of July 31, 2024, which will support the development and commercialization of their AVERSA Fentanyl product.

Portfolio Pulse from Benzinga Newsdesk

September 04, 2024 | 11:08 am

GOCO

GoHealth, Inc. (NASDAQ:GOCO) is set to acquire e-TeleQuote Insurance, Inc., a Medicare insurance marketplace firm. The acquisition is expected to close by September 30, 2024, and aims to enhance consumer experiences and drive growth.

Portfolio Pulse from Benzinga Newsdesk

September 04, 2024 | 11:06 am

BYU

Baiyu Holdings, through its subsidiary, has signed a letter of intent with Adler International to collaborate on building and operating charging and swapping stations in Cairo, Egypt.

Portfolio Pulse from Benzinga Newsdesk

September 04, 2024 | 11:06 am

BWMN

Bowman Consulting Group has been contracted to provide engineering services for safety improvements on Roosevelt Boulevard in Philadelphia. This project could enhance Bowman's reputation and lead to further contracts.

Portfolio Pulse from Benzinga Newsdesk

September 04, 2024 | 11:05 am

AXSM

Axsome Therapeutics announced that the FDA has acknowledged the resubmission of its New Drug Application for AXS-07, a treatment for acute migraine. The FDA has classified it as a Class 2 resubmission with a PDUFA action goal date set for January 31, 2025.

Portfolio Pulse from Benzinga Newsdesk

September 04, 2024 | 11:04 am

CRM

FEPI

IGV

Salesforce (CRM) shares are slightly down despite a strong earnings report and a new acquisition of AI company Tenyx. The acquisition aims to enhance Salesforce's AI capabilities in customer service. Investors can also gain exposure through ETFs like IGV and FEPI.

Portfolio Pulse from Nabaparna Bhattacharya

September 04, 2024 | 11:02 am

GTLB

NVDA

PD

QQQ

SPY

ZS

US stock futures are down, with the VIX spiking 10% and Bitcoin sliding. Nvidia is down over 1% in premarket trading. Analysts suggest focusing on defensive stocks amid mixed economic data. GitLab surged 17% on earnings, while PagerDuty and Zscaler fell over 14%.

Portfolio Pulse from Shanthi Rexaline

September 04, 2024 | 11:01 am